⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBIO News
Crescent Biopharma, Inc. Common Stock
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
globenewswire.com
CBIO
Comanche Biopharma Appoints Richard Colvin, MD, PhD as Global Head of R&D and John McHutchison, AO, MD as Chairman and Director of Comanche Biopharma Australia
globenewswire.com
CBIO
BBIO
NVS
TUNE
VELI
ASMB
GILD
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
globenewswire.com
CBIO
Crescent Biopharma to Present at November Investor Conferences
globenewswire.com
CBIO
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
globenewswire.com
CBIO